1
No significant difference of pentraxin 3 levels was found between mild and severe preeclampsia.
2
Conclusions: There is a strong and specific association between various types of antiprothrombin antibodies with severe preeclampsia and spontaneous abortion.
3
It is engaged in the development of Digoxin immune fab, a polyclonal antibody for the treatment of severe preeclampsia in pregnant women.
4
Conclusions: High maternal serum levels MIF in pregnancies complicated by severe preeclampsia strongly support the role of inflammation in the pathogenesis of this disease.
5
We conclude that, with these dosages and in case of an already established disease, vitamin E does not improve fetal outcome in severe preeclampsia.
1
She developed severe pre-eclampsia and needed an emergency caesarean.
2
Purpose: To present a patient with bilateral permanent concentric visual field defect secondary to severe pre-eclampsia.
3
Population: Women with diagnosis of early-onset severe pre-eclampsia.
4
Tweetable abstract: In early-onset severe pre-eclampsia, longitudinal changes in sFlt-1 levels improve the prediction of complications and interval to delivery.
5
Conclusion: We found a high level of preventable morbidity in cases of severe pre-eclampsia with a concerning number of preventable eclampsia.
6
Objective: To assess in women with early-onset severe pre-eclampsia whether longitudinal changes in angiogenic factors improve the prediction of adverse outcome.
7
Women with severe pre-eclampsia were found to have low values and to some extent the oestrone level could predict fetal outcome.
8
Differential MIF concentrations have been correlated with pathological events during pregnancy, such as recurrent miscarriages and severe pre-eclampsia (PE).
9
We report a case of geographic or mosaic pattern yellowish opaque foci in the left eye of a 36-year-old woman who suffered from severe pre-eclampsia.
10
Women were between 24 and 34 completed weeks and had either HELLP syndrome, severe pre-eclampsia, eclampsia or hypertension and fetal growth restriction.
11
Objectives: Severe pre-eclampsia and eclampsia are one of the major causes of maternal mortality globally.